Clear cell carcinoma of the breast with solid papillary pattern: A case report with immunohistochemical profile

Journal of Clinical Pathology

Volumn 56, Issue 7, 2003, Pages 552-554

  Gurbuz Y ^a   Ozkara S K ^a,b  

^a KOCAELI UNIVERSITY   (Turkey)

^b Mustafa Pasa Mahallesi   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; CARCINOEMBRYONIC ANTIGEN; CHROMOGRANIN; CYTOKERATIN; CYTOKERATIN 10; CYTOKERATIN 14; CYTOKERATIN 17; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 20; CYTOKERATIN 34BETAE12; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 7; CYTOKERATIN AE3; ESTROGEN RECEPTOR; GLYCOGEN; PROGESTERONE RECEPTOR; PROTEIN S 100; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; ARTICLE; BREAST CARCINOMA; CASE REPORT; CLEAR CELL CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MASTECTOMY; PAPILLARY CARCINOMA; PRIORITY JOURNAL;

ADENOCARCINOMA, CLEAR CELL; ANTIGENS, CD; BREAST NEOPLASMS; CYTOPLASM; FEMALE; GLYCOGEN; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MIDDLE AGED; VIMENTIN;

EID: 17444451058     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.7.552     Document Type: Article

References (16)

1. Tavassoli FA. Infiltrating carcinoma: special types. In: Pathology of the breast, 2nd ed. Stanford Connecticut: Appleton & Lange, 1999:481-570.
2. Toikkanen S, Juensuu H. Glycogen rich clear cell carcinoma of the breast: a clinicopathologic and flow cytometric study. Hum Pathol 1991;22:81-3.
3. Hayes MMM, Seidman JD, Asthon MA. Glycogen-rich clear cell carcinoma of the breast. A clinicopathologic study of 21 cases. Am J Surg Pathol 1995;19:904-11.
4. Hull MT, Warfel KA. Glycogen-rich clear cell carcinomas of the breast. A clinicopathologic and ultrastructural study. Am J Surg Pathol 1986;10:553-9.
5. Mooney EE, Tavassoli FA. Papillary transitional cell carcinoma of the breast: a report of 5 cases with distinction from ecrine acrospiroma. Mod Pathol 1999;12:287-94.
6. Maluf HM, Koerner FC. Solid papillary carcinoma of the breast. A form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma. Am J Surg Pathol 1995;19:1237-44.
7. Ordonez NG, Rosai J. Urinary tract, kidney, renal pelvis and ureter, bladder and male urethra. In: Rosai J, ed. Ackerman's surgical pathology, 8th ed. St Louis: Mosby, 1996:1059-220.
8. Rosai J. Breast. Ackerman's surgical pathology, 8th ed. St Louis: 1996:1565-660.
9. Monifar F, Man YG, Liningr RA, et al. Use of cytokeratin 34 beta E12 as an adjuct in the diagnosis of mammary intraepithelial neoplasia-ductal type benign and malignant intraductal proliferations. Am J Surg Pathol 1999;23:1048-58.
10. Dairkee SH, Puett L, Hackett AJ. Expression of basal and luminal epithelium specific keratins in normal, benign and malignant breast tissue. Natl Cancer Inst 1988;80:691-5.
11. Gown AM, Vogel AM. Monoclonal antibodies to human intermediate filamentous proteins. III. Analysis of tumours. Am J Clin Pathol 1985;84:413-24.
12. Renshaw AA, Zhang H, Corless CL, et al. Solid variant of papillary clear cell carcinoma: clinicopathologic and genetic features. Am J Surg Pathol 1997;21:1203-9.
13. Renshaw AA, Corless CL. Papillary renal carcinoma. Histopathology and immunohistopathology. Am J Surg Pathol 1995;19:842-9.
14. Domagala W, Wozniak L, Lasota J, et al. Vimentin is preferentially expressed in high grade ductal and medullary, but not in labular breast carcinomas. Am J Pathol 1990;137:1059-64.
15. Dwarakanath S, Lee AK, Dellelias RA, et al. S-100 protein positivity in breast carcinomas: a potential pitfall in diagnostic immunohistochemistry. Hum Pathol 1987;18:1144-8.
16. Kusama K, Asano M, Moro I, et al. Tumor markers in human renal cell carcinoma. Tumour Biol 1991;12:189-97.